Cargando…
Revisiting the neuroinflammation hypothesis in Alzheimer’s disease: a focus on the druggability of current targets
Alzheimer’s disease (AD) is the most common form of neurodegenerative disease and disability in the elderly; it is estimated to account for 60%–70% of all cases of dementia worldwide. The most relevant mechanistic hypothesis to explain AD symptoms is neurotoxicity induced by aggregated amyloid-β pep...
Autores principales: | Wong-Guerra, Maylin, Calfio, Camila, Maccioni, Ricardo B., Rojo, Leonel E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288808/ https://www.ncbi.nlm.nih.gov/pubmed/37361208 http://dx.doi.org/10.3389/fphar.2023.1161850 |
Ejemplares similares
-
Scaling the Andean Shilajit: A Novel Neuroprotective Agent for Alzheimer’s Disease
por: Andrade, Víctor, et al.
Publicado: (2023) -
Novel Nutraceutical Compounds in Alzheimer Prevention
por: Maccioni, Ricardo Benjamin, et al.
Publicado: (2022) -
Does neuroinflammation turn on the flame in Alzheimer's disease? Focus on astrocytes
por: Steardo, Luca, et al.
Publicado: (2015) -
Neuroinflammation as a Common Feature of Neurodegenerative Disorders
por: Guzman-Martinez, Leonardo, et al.
Publicado: (2019) -
Glucose metabolism and AD: evidence for a potential diabetes type 3
por: González, Andrea, et al.
Publicado: (2022)